Clinical study of biapenem in otorhino otorhinolaryngology

Abstract

The effectiveness and safety of the new carbapenem antibiotic, biapenem (BIPM), for infections in the otorhinolaryngological field were evaluated. The drug was administered to 23 patients, but 1 was excluded from the study. Clinical efficacy rate 77.3% and as for bacteriological efficacy, the eradication rate was 83.3% in 22 cases. No adverse drug reaction or abnormal laboratory findings were observed in all cases. The results suggest that the drug is extremely effective and useful for bacterial infections in the otorhinolaryngological field.